US stocks opened August with strong gains, pushing the Dow Industrials to a record closing high. Easing oil prices and Treasury yields supp...

Indian equities rallied sharply as easing oil prices following renewed US-Iran talks boosted sentiment. Sensex gained 544 points and Nifty ...

Major US stock indexes opened higher on Monday. De-escalating Middle East tensions helped drag down crude oil prices. Investors are now pre...

According to Reuters, investor sentiment improved after Trump signalled a preference for diplomacy over immediate military action against I...

Artificial sweeteners, discovered by chance, offer temporary sugar relief for many individuals. Experts suggest long-term use can negativel...

Andhra Pradesh signed an MoU with AstraZeneca for an integrated precision oncology ecosystem. This initiative will integrate artificial int...

Zimbabwe captain Sikandar Raza won the toss and elected to field first. India leads the three-match series one-nil after their previous vic...

Global markets face a pivotal week as the Federal Reserve, Bank of Japan and Bank of England meet against the backdrop of the Middle East c...

AstraZeneca's nerve drug Wainua unexpectedly failed a late-stage heart disease trial. This setback has caused investor concern and impacted...

Bristol Myers Squibb is buying Nvidia's latest AI computing system. This new system will support artificial intelligence in drug discovery ...

The artificial intelligence boom has propelled Dutch chip equipment maker ASML to become Europe's most valuable listed technology company, ...

Natco Pharma shares rose sharply on Monday after the U.S. FDA granted tentative approval for its generic Olaparib tablets, a bioequivalent ...

Alembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...

Samsung Electronics denied exploring a U.S. listing of American Depositary Receipts. Bloomberg News had reported preliminary discussions wi...

Dizal Pharmaceutical shares rose significantly after announcing a major drug rights deal. AstraZeneca will pay $600 million upfront for glo...

European stock markets traded higher on Thursday, recovering from previous losses. Technology shares led the gains, driven by renewed inter...

AstraZeneca shares fell after Wainua failed a key trial. The drug did not reduce cardiovascular deaths or heart problems. Wainua showed no ...